2,3,5-triphenyl tetrazolium chloride as colorimetric indicator for drug susceptibility testing against nontuberculous mycobacteria

Diagn Microbiol Infect Dis. 2024 Jan;108(1):116096. doi: 10.1016/j.diagmicrobio.2023.116096. Epub 2023 Sep 24.

Abstract

This study aimed to propose and evaluate a drug susceptibility testing (DST) using the 2,3,5-triphenyl tetrazolium chloride (TTC) as a colorimetric indicator against Mycobacterium abscessus complex (MABC), M. avium complex (MAC), and M. kansasii strains, main nontuberculous mycobacteria (NTM) of clinical relevance. Our results demonstrated that the assay using TTC and the broth microdilution method recommended by the Clinical and Laboratory Standards Institute had essential agreement above 91%, 92%, and 100%, for drugs tested against MABC, MAC, and M. kansasii strains, respectively. Categorical agreement above 91% was obtained for most drugs tested against MABC, except to cefoxitin (76.5%). For drugs tested against MAC and M. kansasii, categorical agreement above 92% and 100% was observed, respectively. TTC showed to be a promising colorimetric indicator of growth to be used in DST for NTM, allowing an easier reading of results.

Keywords: Formazan; Minimum inhibitory concentration; Mycobacterium; Tetrazolium salt.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Chlorides
  • Colorimetry
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium Infections, Nontuberculous* / microbiology
  • Mycobacterium abscessus*
  • Mycobacterium tuberculosis*
  • Nontuberculous Mycobacteria

Substances

  • Anti-Bacterial Agents
  • Chlorides